577 filings
Page 5 of 29
CORRESP
y43i5z7
5 Mar 21
Correspondence with SEC
12:00am
CORRESP
zpkn meo5fkvipt
5 Mar 21
Correspondence with SEC
12:00am
6-K
20vv633clhy9av3w
4 Mar 21
Current report (foreign)
8:09am
UPLOAD
8jpr0e0zubvqet 4lnp
4 Mar 21
Letter from SEC
12:00am
6-K
4gk9d
2 Mar 21
Portage Announces Filing of Third Quarter Financial Statements
8:13am
6-K
xcev1dvy7p nc3u
1 Mar 21
Condensed Consolidated Interim Financial Statements
4:23pm
6-K
77w8jr 68x04m6sl
25 Feb 21
Current report (foreign)
8:11am
F-3
hyaecha6oyxpvff
24 Feb 21
Shelf registration (foreign)
5:22pm
CERT
k0vs1glcoaznw1x xv
24 Feb 21
Certification of approval for exchange listing
5:04pm
8-A12B
km2aj7pt
18 Feb 21
Registration of securities on exchange
12:46pm
6-K
rbs 74echl3nqcs
11 Feb 21
Portage Biotech Provides Research and Development Update and Announces Nasdaq Listing Approval
4:30pm
6-K
f9p 3z8kji1d
1 Dec 20
Condensed Consolidated Interim Financial Statements
7:13am
6-K
0tx1a7i6tcinpb
16 Oct 20
Portage Announces Filing of Q1 Interim Financial Statements; Correction to Salvarx Loan Note Settlement Announcement
4:12pm
6-K
9fdmltqj3ddv 6i
16 Oct 20
Consolidated Interim Financial Statements
2:44pm
6-K
n2ug12j74nc9zm94q6x0
13 Oct 20
Portage Issues Common Shares and Warrants In Settlement of Salvarx Loan Note Obligations
10:15am
NT 20-F
kczw4eflpq0irb
31 Jul 20
Notice of late annual filing (foreign)
2:51pm
6-K
cz0n7kc zvgg
30 Jun 20
Report of Foreign Private Issuer
1:11pm
6-K
kzozglkg
17 Jun 20
Report of Foreign Private Issuer
10:46am
6-K
t4uq6fblyedoln
4 Jun 20
Report of Foreign Private Issuer
11:58am